# Supplemental Postoperative Bupivacaine Following Non-Surgical Endodontic Treatment

> **NCT06655454** · PHASE2 · RECRUITING · sponsor: **New York University** · enrollment: 150 (estimated)

## Conditions studied

- Pain Assessment
- Quality of Life (QOL)
- Analgesic Use

## Interventions

- **DRUG:** Supplemental Postoperative Bupivacaine
- **DRUG:** Placebo Injection

## Key facts

- **NCT ID:** NCT06655454
- **Lead sponsor:** New York University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06655454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06655454, "Supplemental Postoperative Bupivacaine Following Non-Surgical Endodontic Treatment". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06655454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*